9 completed, 2 unknown, 1 active not recruiting, 1 not yet recruiting. 15 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 15 | Completed 9, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Terminated 1 |
| Phase 2 | 4 | Completed 2, Recruiting 1, Terminated 1 |
Follow Transient Ischemic Attack: new trials by email Literature Review of Transient Ischemic Attack trials Research Report on Transient Ischemic Attack
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke Zastaprazan, Placebo - Ischemic Stroke, Transient Ischemic Attack | Phase 3 | Not yet recruiting | Asan Medical Center | 984 | 2026-10-15 | 2026-10-09 |
| Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis Regular physical exercise, Control group - Ischemic Stroke, Transient Ischemic Attack | Phase 3 | Active not recruiting | Capital Medical University | 1300 | 2024-10-10 | 2025-11-25 |
| Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke Ticagrelor 60 + Aspirin, Ticagrelor 90 + aspirin - Ischemic Stroke, Transient Ischemic Attack | Phase 2 / Phase 3 | Recruiting | Mazandaran University of Medical Sciences | 100 | 2024-04-01 | 2025-04-27 |
| Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke Ticagrelor 90mg, Clopidogrel 75 mg - Ischemic Stroke, Transient Ischemic Attack | Phase 3 | Completed | Mazandaran University of Medical Sciences | 90 | 2021-08-08 | 2023-10-19 |
| NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events dl-3-n-butylphthalide (NBP), Normal Saline 0.9% Infusion Solution - Moyamoya Disease, Ischemic Cerebral Infarction | Phase 3 | Unknown | yuanli Zhao | 450 | 2020-01-01 | 2019-12-19 |
| Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II Ticagrelor and Aspirin, Clopidogrel and Aspirin - Stroke, Transient Ischemic Attack | Phase 3 | Completed | Beijing Tiantan Hospital | 6412 | 2019-09-23 | 2021-12-02 |
| Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis Intensive antiplatelet, Standard antiplatelet, Immediate high-intensity statin - Acute Stroke, Transient Ischemic Attack | Phase 3 | Unknown | Beijing Tiantan Hospital | 6100 | 2018-09-17 | 2023-07-18 |
| Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation Apixaban, Warfarin - Transient Ischemic Attack, Stroke | Phase 3 | Completed | University of South Florida | 91 | 2015-04-01 | 2021-11-30 |
| Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events Clopidogrel, Placebo of clopidogrel and Asprin - Stroke, Transient Ischemic Attack | Phase 3 | Completed | Beijing Tiantan Hospital | 5100 | 2009-12-01 | 2020-07-15 |
| Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA) - Obstructive Sleep Apnea, Stroke | Phase 2 / Phase 3 | Completed | VA Office of Research and Development | 225 | 2008-12-23 | 2017-06-14 |
| VISSIT Intracranial Stent Study for Ischemic Therapy Pharos Vitesse Neurovascular Stent System (Stent implantation) + Medical therapy (Aspirin and Clopidogrel), Aspirin and Clopidogrel (Medical therapy) - Ischemic Stroke, Transient Ischemic Attack | Phase 2 / Phase 3 | Terminated | Codman & Shurtleff | 125 | 2008-10-01 | 2015-02-20 |
| Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER) Aspirin, Clopidogrel, Simvastatin - Transient Ischemic Attack, Stroke | Phase 2 / Phase 3 | Completed | University of Calgary | 500 | 2003-05-01 | 2008-04-08 |
| Aortic Arch Related Cerebral Hazard Trial (ARCH) Warfarin, Clopidogrel-aspirin - Brain Infarction, Transient Ischemic Attack | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 350 | 2002-02-01 | 2012-07-10 |
| Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ EndoTex™ NexStent™, Filter Wire EZ™ - Transient Ischemic Attack, Thromboembolic Stroke | Phase 3 | Completed | Boston Scientific Corporation | 488 | 2001-12-01 | 2008-01-24 |
| EVA3S: Endarterectomy Versus Angioplasty in Patients With Severe Symptomatic Carotid Stenosis Carotid angioplasty and stenting with cerebral protection - Transient Ischemic Attack, Carotid Stenosis | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 900 | 2000-11-01 | 2011-05-02 |
Ischemic Attack, Transient (15) · Ischemic Stroke (7) · Stroke (7) · Recurrence (2) · Atherosclerosis (1) · Atrial Fibrillation (1) · Brain Infarction (1) · Brain Ischemia (1) · Carotid Stenosis (1) · Embolism (1) · Hypertension (1) · Moyamoya Disease (1) · Sleep Apnea Syndromes (1) · Sleep Apnea, Obstructive (1) · Thrombosis (1)
Brain Diseases (15) · Cardiovascular Diseases (15) · Central Nervous System Diseases (15) · Cerebrovascular Disorders (15) · Nervous System Diseases (15) · Vascular Diseases (15) · Brain Ischemia (14) · Stroke (8) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Arterial Occlusive Diseases (2) · Carotid Artery Diseases (2) · Disease Attributes (2) · Embolism and Thrombosis (2) · Apnea (1)
Aspirin (6) · Clopidogrel (5) · Ticagrelor (2) · Warfarin (2) · 3-n-butylphthalide (1) · Control Groups (1) · Saline Solution (1) · Simvastatin (1) · Stents (1) · apixaban (1)
Beijing Tiantan Hospital (3) · Assistance Publique - Hôpitaux de Paris (2) · Mazandaran University of Medical Sciences (2) · Asan Medical Center (1) · Boston Scientific Corporation (1) · Capital Medical University (1) · Codman & Shurtleff (1) · University of Calgary (1) · University of South Florida (1) · VA Office of Research and Development (1) · yuanli Zhao (1)
China (5) · United States (4) · France (2) · Iran (2) · Argentina (1) · Australia (1) · Canada (1) · Germany (1) · South Korea (1)
Alastair M Buchan (1) · Athena Sharifi-Razavi (1) · Bum Joon Kim, Ph.D. (1) · Cheryl Fontana, BSN (1) · Dawn M. Bravata, MD (1) · James Kennedy (1) · L. Nelson Hopkins, MD (1) · Michael Fradley, M.D. (1) · Pierre Amarenco, Pr, MD, PhD (1) · S.Claiborne NA Johnston, M.D, Ph.D (1) · Subbarao Myla, MD (1) · Yilong Wang, MD, PhD (1) · Yongjun NA Wang, M.D (1) · Yongjun Wang, M.D (1)
PMID 17050890, PMID 17931979, PMID 18774745, PMID 20542776, PMID 21885958, PMID 22334806, PMID 22968110, PMID 23237679, PMID 23803136, PMID 24458967, PMID 24699050, PMID 25082808, PMID 25803346, PMID 25957224, PMID 26012640, PMID 26330567, PMID 27001965, PMID 27328699, PMID 27613582, PMID 27738237, PMID 28289237, PMID 28455318, PMID 28959461, PMID 29051218, PMID 29507777, PMID 29773949, PMID 30089614, PMID 30355101, PMID 30355199, PMID 30355202, PMID 30621613, PMID 30742211, PMID 30972875, PMID 31127478, PMID 31378071, PMID 31620067, PMID 31726963, PMID 31822574, PMID 31941381, PMID 32355775, PMID 32606085, PMID 32958697, PMID 33093222, PMID 33493046, PMID 33626904, PMID 33952670, PMID 34708996, PMID 35224730, PMID 35256525, PMID 35656824